A patient-centered approach to pharmaceutical prescribing to treat hyperglycemia in diabetes mellitus type 2 (DM2) and review of appropriate levels of intervention based on patient status, goals, and risk. Succinct review of different classes of oral and injectable medications used to treat DM2, including mechanism of action, indications, contraindications, common side effects, monitoring parameters, and special considerations such as use in populations with cardiovascular disease, heart failure, and chronic kidney disease. The review will include highlights on current research and standards of care regarding the following diabetes medications: biguanides (metformin), sulfonylureas, DPP-4 inhibitors, thiazolidinediones (TZDs), GLP-1 agonists, and SGLT2 inhibitors. Insulin will be touched on briefly to include the basic characteristics and indications. Helpful pharmaceutical resources will be reviewed to aid in choosing the right medication for patients. In addition, the review will have an integrated approach by highlighting adjunctive herbal and supplemental treatments to offset nutrient deficiencies and side effects of pharmaceuticals.
Speaker Bio:Dr. Marisa Pellegrini earned their doctoral degree in naturopathic medicine from Bastyr University in 2010. Following graduation, they completed three years of residency at Bastyr’s teaching clinic, Bastyr Center for Natural Health (BCNH), including serving as Chief Resident. Dr. Pellegrini currently serves as an Associate Professor at Bastyr University and Director of the Diabetes and Cardiovascular Wellness Clinic. Dr. Pellegrini is dedicated to their work as both a naturopathic physician and teacher at Bastyr University. They work as a clinical supervisor training medical students to be primary care physicians and also as a didactic instructor for Endocrinology and several electives on diabetes and cardiovascular disease. Dr. Pellegrini is passionate about their work as a primary care physician integrating conventional and naturopathic medicine to treat a wide variety of acute and chronic health conditions with a special interest in diabetes and cardiovascular disease. Dr. Pellegrini has had an opportunity to speak on both the national and international level and spread their passion for integrative management of diabetes and cardiovascular disease.
*Certified by the WANP for 1 Category 1 continuing education credit (including 1 Pharmacology credit) for Washington NDs*
(Originally presented on October 9, 2020)